Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001

American Journal of the Medical Sciences

Volumn 330, Issue 2, 2005, Pages 65-68

  Gillis, Leslie M ^a   White, Heather D ^a   Whitehurst, Anne ^b   Sullivan, Donna C ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Streptococcus pneumoniae; Vancomycin tolerance

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 23744478289     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200508000-00003     Document Type: Article

References (13)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1997;15:77-83.
2. Gieseck J, Fredlund H. Increase in pneumococcal bacteremia in Sweden. Lancet 1997;349:699-700.
3. Thornsberry C, Ogilvie PT, Holley HP et al. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective US study. Antimicrob Agents Chemother 1999;43:2612-23.
4. Sahm DF, Karlowsky JA, Kelly LJ et al. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob Agents Chemother 2001;45:1037-42.
5. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis 2001;33:S187-92.
6. Boost MV, Ko WM, O'Donoghue, MM. Penicillin and vancomycin tolerance among clinical isolates of Streptococcus pneumoniae in Hong Kong. Hong Kong Med J 2003;9:415-8.
7. Normark BH, Novak R, Ortqvist A et al. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001;32:552-8.
8. McCullers JA, English BK, Novak R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 2000;181:369-73.
9. Novak R, Henriques B, Charpentier E et al. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999;399:590-3.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, 6th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourteenth informational supplement. M100-S14. 2004. Vol. 24. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000:120-1.
12. Chapin KC, Lauderdale TL. In Murray P, Baron EJ, Jorgensen JH, et al, editors. Manual of clinical microbiology, 8th ed. Washington, DC: ASM Press; 2003:354-83.
13. Tuomanen E, Pollack H, Parkinson A et al. Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci. J Infect Dis 1988;152:365-72.